Uncategorized

Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces its participation in the 27th Annual American Society of Cell and Gene Therapy Meeting, taking place on May 7-11, 2024, in Baltimore, United States of America.

Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting Read More »

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants

Vincerx Pharma, Inc. announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock and accompanying common stock warrants to purchase an aggregate of 6,000,000 shares of common stock, and to certain investors, pre-funded warrants to purchase up to an aggregate of 16,000,000 shares of common stock and accompanying common stock

Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants Read More »

Scroll to Top